Cartherics

Private

Notting HillHealthcare & Life Scienceshttps://cartherics.com/

Last Round

Series C

Oct 1, 2024

Total Funding Raised

$20.55M

Company Overview

Cartherics is a biotechnology company that develops off-the-shelf immune cell therapies for the treatment of cancer and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyallogeneic cell therapyoff-the-shelf therapyCAR-NK cell therapyinduced pluripotent stem cellsiPSCsimmunotherapycell and gene therapyNatural Killer cellsNK cellsChimeric Antigen ReceptorCARsolid tumor therapyclinical-stage biotechgene editingCAR-T cell therapyovarian cancer treatmentwomen's health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cartherics Comparables

Compare Cartherics with similar companies based on industry and business-model similarity.

Cartherics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
iCamuno Biotherapeutics	84%
Shoreline Biosciences	82%
Neukio Biotherapeutics	82%

View all Comparables

Cartherics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Oct 1, 2024
Grant	Sep 27, 2022
Grant	Jul 28, 2020
Series C	Aug 21, 2019
Grant	Dec 22, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Alan Trounson AO

Chief Executive Officer, Deputy Chair

Executive Team

Ian Nisbet

Co-Founder And CEO

Founding Team

Cartherics Investors

Notable investors and investment history

Cartherics investors
Investor	Rounds
Monash University	Grant
Hudson Institute of Medical Research	Grant
Entrepreneurs' Programme	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 20, 2026
Monthly visitors increased 44% MoM.
Jul 2, 2025
Monthly visitors increased 148% MoM, reaching 5.7K.

View all signals

Cartherics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cartherics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cartherics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNotting Hill

Employee Range36

Year Founded2016

Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.